Smruthi Organics logo

540686 - Smruthi Organics Share Price

₹299.9 0.7  0.2%

Last Trade - 10:42am

Micro Cap
Market Cap £33.2m
Enterprise Value £32.6m
Revenue £12.4m
Position in Universe 1423rd / 3159
Unlock 540686 Revenue
Relative Strength (%)
1m -11.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
725.8 793.5 973.4 1,374 1,311 1,265 +11.8%
+119.6 +23.1 +102.6
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 30 June 2021, SmruthiOrganics Ltd revenues increased 5% to RS309M. Net incomedecreased 15% to RS25.3M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income was offset byEmployee benefits expense increase of 44% to RS43.6M(expense), Other Expenses increase of 35% to RS38.3M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


540686 Revenue Unlock 540686 Revenue

Net Income

540686 Net Income Unlock 540686 Revenue

Normalised EPS

540686 Normalised EPS Unlock 540686 Revenue

PE Ratio Range

540686 PE Ratio Range Unlock 540686 Revenue

Dividend Yield Range

540686 Dividend Yield Range Unlock 540686 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
540686 EPS Forecasts Unlock 540686 Revenue
Profile Summary

Smruthi Organics Limited is engaged in the manufacture and sale of bulk drugs and drug intermediates (active pharmaceutical ingredient (API) products). The Company's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The Company has approximately two manufacturing facilities in Solapur, Maharashtra, India, with a combined reactor capacity of over 320 kiloliters. The Company manufactures API from kilo to metric ton scale. The Company serves pharmaceutical companies in India and across the globe.

Last Annual March 31st, 2021
Last Interim June 30th, 2021
Incorporated July 11, 1989
Public Since August 29, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Exchange Bombay Stock Exchange
Shares in Issue 11,446,290
Free Float (0.0%)
Eligible for
540686 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 540686
Upcoming Events for 540686
Frequently Asked Questions for Smruthi Organics
What is the Smruthi Organics share price?

As of 10:42am, shares in Smruthi Organics are trading at ₹299.9, giving the company a market capitalisation of £33.2m. This share price information is delayed by 15 minutes.

How has the Smruthi Organics share price performed this year?

Shares in Smruthi Organics are currently trading at ₹299.9 and the price has moved by 0.257k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Smruthi Organics price has moved by 0.128k% over the past year.

What are the analyst and broker recommendations for Smruthi Organics?

Of the analysts with advisory recommendations for Smruthi Organics, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Smruthi Organics is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Smruthi Organics next release its financial results?

Smruthi Organics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Smruthi Organics dividend yield?

The Smruthi Organics dividend yield is 1% based on the trailing twelve month period.

Does Smruthi Organics pay a dividend?

Last year, Smruthi Organics paid a total dividend of 3, and it currently has a trailing dividend yield of 1%. Looking ahead, Smruthi Organics has not announced an ex-dividend date yet.

When does Smruthi Organics next pay dividends?

Smruthi Organics has yet to annouce their ex-dividend date. The historic dividend yield on Smruthi Organics shares is currently 1%.

How do I buy Smruthi Organics shares?

To buy shares in Smruthi Organics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Smruthi Organics?

Shares in Smruthi Organics are currently trading at ₹299.9, giving the company a market capitalisation of £33.2m.

Where are Smruthi Organics shares listed? Where are Smruthi Organics shares listed?

Here are the trading details for Smruthi Organics:

Country of listing: India
Exchange: BSE
Ticker Symbol: 540686
What kind of share is Smruthi Organics?

Based on an overall assessment of its quality, value and momentum, Smruthi Organics is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Smruthi Organics share price forecast 2021?

We were not able to load any forecast data for Smruthi Organics.

How can I tell whether the Smruthi Organics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Smruthi Organics. Over the past six months, the relative strength of its shares against the market has been -6.05%. At the current price of ₹299.9, shares in Smruthi Organics are trading at 9.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Smruthi Organics PE Ratio?

The Smruthi Organics PE ratio based on its reported earnings over the past 12 months is 20.57. The shares are currently trading at ₹299.9.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Smruthi Organics?

Smruthi Organics's management team is headed by:

Eaga Purushotham - CHM
Eaga Vaishnavi - NED
J. Ranade - NID
Eaga Swapnil - CFO
K. Rama Swamy - NID
Vijay Changale - CCO
Urvashi Khanna - SEC
Who are the major shareholders of Smruthi Organics?

Here are the top five shareholders of Smruthi Organics based on the size of their shareholding:

Eaga (Purushottam) Individual Investor
Percentage owned: 40.47% (4.63m shares)
Eaga (Vaishnavi) Individual Investor
Percentage owned: 15.11% (1.73m shares)
Eaga (Swapnil Purushotham) Individual Investor
Percentage owned: 4.98% (570k shares)
Smruthi Chemicals & Intermediates Pvt. Ltd. Corporation
Percentage owned: 2.15% (246k shares)
Gupta (Salil) Individual Investor
Percentage owned: 1.01% (115k shares)
Similar to 540686
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.